Last Updated: May 10, 2026

RUBICON RESEARCH Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for RUBICON RESEARCH

RUBICON RESEARCH has seventy-five approved drugs.

Summary for RUBICON RESEARCH

US Patents:	0
Tradenames:	61
Ingredients:	60
NDAs:	75

Drugs and US Patents for RUBICON RESEARCH

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rubicon Research	RABEPRAZOLE SODIUM	rabeprazole sodium	TABLET, DELAYED RELEASE;ORAL	204237-001	Nov 18, 2015	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	PRIMIDONE	primidone	TABLET;ORAL	214896-001	Jun 28, 2022	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	POTASSIUM CHLORIDE	potassium chloride	TABLET, EXTENDED RELEASE;ORAL	216321-002	Jun 16, 2023	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	POTASSIUM CHLORIDE	potassium chloride	FOR SOLUTION;ORAL	214108-001	Mar 24, 2022	AA	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	CARVEDILOL	carvedilol	TABLET;ORAL	078165-001	Sep 5, 2007	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	212543-002	Aug 19, 2019	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Rubicon Research	BACLOFEN	baclofen	SOLUTION;ORAL	214445-001	Dec 6, 2024		RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.